Catalyst Pharmaceuticals Stock Price Prediction

CPRX Stock  USD 15.94  0.33  2.03%   
At this time, The RSI of Catalyst Pharmaceuticals' share price is at 57 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Catalyst Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
Catalyst Pharmaceuticals stock price prediction is an act of determining the future value of Catalyst Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Catalyst Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Catalyst Pharmaceuticals and does not consider all of the tangible or intangible factors available from Catalyst Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Catalyst Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Catalyst Pharmaceuticals' stock price prediction:
Quarterly Earnings Growth
0.346
EPS Estimate Next Quarter
0.32
EPS Estimate Current Year
1.16
EPS Estimate Next Year
1.53
Wall Street Target Price
27
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Catalyst Pharmaceuticals based on different types of headlines from major news networks to social media. The Catalyst stock price prediction module provides an analysis of price elasticity to changes in media outlook on Catalyst Pharmaceuticals over a specific investment horizon. Using Catalyst Pharmaceuticals hype-based prediction, you can estimate the value of Catalyst Pharmaceuticals from the perspective of Catalyst Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Catalyst Pharmaceuticals using Catalyst Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Catalyst using crowd psychology based on the activity and movement of Catalyst Pharmaceuticals' stock price.

Catalyst Pharmaceuticals Short Interest

A significant increase or decrease in Catalyst Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Catalyst. Short interest can provide insight into the potential direction of Catalyst Pharmaceuticals stock and how bullish or bearish investors feel about the market overall. An investor who is long Catalyst Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Catalyst Pharmaceuticals and may potentially protect profits, hedge Catalyst Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA
13.9281
Short Percent
0.0677
Short Ratio
5.01
Shares Short Prior Month
6.5 M
50 Day MA
14.9754

Catalyst Pharmaceuticals Hype to Price Pattern

Investor biases related to Catalyst Pharmaceuticals' public news can be used to forecast risks associated with an investment in Catalyst. The trend in average sentiment can be used to explain how an investor holding Catalyst can time the market purely based on public headlines and social activities around Catalyst Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Catalyst Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals Implied Volatility

    
  39.34  
Catalyst Pharmaceuticals' implied volatility exposes the market's sentiment of Catalyst Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Catalyst Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Catalyst Pharmaceuticals stock will not fluctuate a lot when Catalyst Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Catalyst Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Catalyst Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Catalyst because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Catalyst Pharmaceuticals after-hype prediction price

    
  USD 15.92  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Catalyst Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Catalyst Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
14.3519.3222.61
Details
Naive
Forecast
LowNextHigh
11.5014.7918.08
Details
7 Analysts
Consensus
LowTargetHigh
21.0223.1025.64
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.140.240.34
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Catalyst Pharmaceuticals. Your research has to be compared to or analyzed against Catalyst Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Catalyst Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Catalyst Pharmaceuticals.

Catalyst Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Catalyst Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Catalyst Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Catalyst Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Catalyst Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Catalyst Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Catalyst Pharmaceuticals' historical news coverage. Catalyst Pharmaceuticals' after-hype downside and upside margins for the prediction period are 12.63 and 19.21, respectively. We have considered Catalyst Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
15.94
15.92
After-hype Price
19.21
Upside
Catalyst Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Catalyst Pharmaceuticals is based on 3 months time horizon.

Catalyst Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Catalyst Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Catalyst Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Catalyst Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.06 
3.31
  0.04 
  0.01 
10 Events / Month
6 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
15.94
15.92
0.13 
494.03  
Notes

Catalyst Pharmaceuticals Hype Timeline

Catalyst Pharmaceuticals is currently traded for 15.94. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of -0.01. Catalyst is projected to decline in value after the next headline, with the price expected to drop to 15.92. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.13%, whereas the daily expected return is currently at -0.06%. The volatility of related hype on Catalyst Pharmaceuticals is about 1479.33%, with the expected price after the next announcement by competition of 15.93. About 73.0% of the company shares are held by institutions such as insurance companies. The book value of Catalyst Pharmaceuticals was currently reported as 3.62. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 10 days.
Check out Catalyst Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

Catalyst Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Catalyst Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Catalyst Pharmaceuticals' future price movements. Getting to know how Catalyst Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Catalyst Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
NTGRNETGEAR(0.69)9 per month 2.10 (0) 3.24 (2.94) 13.02 
DYAIDyadic International 0.08 9 per month 2.67  0  5.80 (4.26) 16.85 
INKTMink Therapeutics 0.01 7 per month 0.00 (0.06) 5.81 (7.00) 21.23 
VALNValneva SE ADR 0.27 7 per month 0.00 (0.12) 5.47 (4.94) 19.42 
KNDIKandi Technologies Group(0.04)7 per month 0.00 (0.21) 4.41 (3.77) 11.12 
ABCLAbcellera BiologicsInc 0.02 8 per month 0.00 (0.13) 5.08 (6.33) 16.27 
ATEXAnterix(1.04)8 per month 1.91 (0.03) 3.52 (3.46) 25.32 
TARSTarsus PharmaceuticalsInc(0.40)10 per month 2.41  0.22  7.31 (3.80) 26.77 

Catalyst Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Catalyst price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Catalyst using various technical indicators. When you analyze Catalyst charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Catalyst Pharmaceuticals Predictive Indicators

The successful prediction of Catalyst Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Catalyst Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Catalyst Pharmaceuticals based on analysis of Catalyst Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Catalyst Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Catalyst Pharmaceuticals's related companies.
 2021 2022 2023 2024 (projected)
Price Book Value Ratio3.386.864.934.68
Operating Cycle148.4290.01116.689.44

Story Coverage note for Catalyst Pharmaceuticals

The number of cover stories for Catalyst Pharmaceuticals depends on current market conditions and Catalyst Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Catalyst Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Catalyst Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Catalyst Pharmaceuticals Short Properties

Catalyst Pharmaceuticals' future price predictability will typically decrease when Catalyst Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Catalyst Pharmaceuticals often depends not only on the future outlook of the potential Catalyst Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Catalyst Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding113.8 M
Cash And Short Term Investments137.6 M
When determining whether Catalyst Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Catalyst Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Catalyst Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Catalyst Pharmaceuticals Stock:
Check out Catalyst Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Catalyst Stock analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Catalyst Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalyst Pharmaceuticals. If investors know Catalyst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalyst Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.346
Earnings Share
0.63
Revenue Per Share
3.747
Quarterly Revenue Growth
0.82
Return On Assets
0.1283
The market value of Catalyst Pharmaceuticals is measured differently than its book value, which is the value of Catalyst that is recorded on the company's balance sheet. Investors also form their own opinion of Catalyst Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Catalyst Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalyst Pharmaceuticals' market value can be influenced by many factors that don't directly affect Catalyst Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalyst Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Catalyst Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalyst Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.